Japan relies almost entirely on China for the APIs of β-lactam antibiotics. These drugs are essential for treating infectious diseases…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Pfizer Preparing for Assault on Domestic Generic Drug Market with Help from Mylan
September 24, 2012
-
REGULATORY MHLW to Introduce Brand Name Rules for Combination Injectables to Prevent Medical Accidents
September 21, 2012
-
ORGANIZATION Dr Fukuda Lays Out 4 Options for HTA Introduction in Drug Pricing
September 20, 2012
-
ORGANIZATION Maker FTC Bans Drink Donations at Academic Conferences
September 19, 2012
-
BUSINESS Chugai Provides All-Case PMS Data via iPad, Beginning with Avastin
September 18, 2012
-
BUSINESS JT Sees Silver Lining in Pharmaceutical Biz 25 Yrs after Market Entry; 1st Approval Obtained for Proprietary Drug
September 14, 2012
-
REGULATORY Osaka District Court to Issue Ruling on Actos Patent Suit on Sept. 27
September 12, 2012
-
BUSINESS Wholesalers Unlikely to See Significant Progress in Price Negotiations By End of September
September 12, 2012
-
BUSINESS Pharmaceutical Companies Beefing Up Training for Cancer Specialized MRs
September 11, 2012
-
BUSINESS DSP Revising Midterm Business Plan – Will It Be Able to Hammer Out Effective Measures against Stagnant Domestic Business?
September 10, 2012
-
BUSINESS Kissei Aims for 40% Market Share for Epoetin Alfa at Early Stage
September 7, 2012
-
BUSINESS Nippon Shinyaku Plans Generic Launch to Complement Its New Drug Lineup in Priority Field
September 6, 2012
-
BUSINESS Meiji Seika Pharma Aims to Bolster Presence with COPD Drug Oxis
September 5, 2012
-
BUSINESS RaQualia to Focus on Fields Where It Can Exhibit Uniqueness, Compile Biz Strategy in November
September 4, 2012
-
BUSINESS DSP’s US Subsidiary Sunovion to Acquire Elevation Pharmaceuticals of the US
September 3, 2012
-
REGULATORY MHLW to Seek Funds to Enhance Regulatory Consultation under FY2013 “Priority Budget Scheme”
September 3, 2012
-
BUSINESS Sosei Committed to Becoming a Japan-Based Global Biopharma: Vice President Akihiro Matsuura
September 3, 2012
-
BUSINESS Ribomic Aims to Commercialize Non-Addictive Analgesic Nucleic Acid Drug
August 30, 2012
-
REGULATORY MHLW to Include Creation of Drug Discovery Support Network in FY2013 Draft Budget Request
August 30, 2012
-
BUSINESS Takeda Gearing Up for Emerging Market Operations
August 29, 2012
ページ
Your company’s employer brand is your reputation as an employer and is crucial in attracting top talent. Some reputations are just not good; they may or not be deserved. That is just the perception in the market. Years ago there…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…